TY - JOUR
T1 - Lung function in Lolland-Falster Health study (LOFUS)
AU - Jacobsen, Katja Kemp
AU - Jepsen, Randi
AU - Bodtger, Uffe
AU - Rasmussen, Knud
AU - St-Martin, Gry
N1 - Publisher Copyright:
© 2022 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.
PY - 2022/10
Y1 - 2022/10
N2 - Background: COPD prevalence in Denmark is estimated at 18% based on data from urban populations. However, studies suggest that using the clinical cut-off for airway obstruction in population studies may overestimate prevalence. The present study aims to compare estimated prevalence of airway obstruction using different cut-offs and to present lung function data from the Lolland-Falster Health Study, set in a rural-provincial area. Methods: Descriptive analysis of participant characteristics and self-reported respiratory disease and of spirometry results in the total population and in subgroups defined by these characteristics. Airway obstruction was assessed using previously published Danish reference values and defined according to either FEV
1/FVC below lower limit of normal (LLN) 5% (as in clinical diagnosis) or 2.5% (suggested for population studies), or as FEV
1/FVC < 70%. Results: Using either FEV
1/FVC < 70% or LLN 5% cut-off, 19.0% of LOFUS participants aged 35 years or older had spirometry, suggesting airway obstruction. By the LLN 2.5% criterion, the proportion was considerably lower, 12.2%. The prevalence of airway obstruction was higher among current smokers, in participants with short education or reporting low leisure-time physical activity and in those with known respiratory disease. Approximately 40% of participants reporting known respiratory disease had normal spirometry, and 8.7% without known respiratory disease had airway obstruction. Conclusion: Prevalence of airway obstruction in this rural population was comparable to previous estimates from urban Danish population studies. The choice of cut-off impacts the estimated prevalence, and using the FEV
1/FVC cut-off may overestimate prevalence. However, many participants with known respiratory disease had normal spirometry in this health study.
AB - Background: COPD prevalence in Denmark is estimated at 18% based on data from urban populations. However, studies suggest that using the clinical cut-off for airway obstruction in population studies may overestimate prevalence. The present study aims to compare estimated prevalence of airway obstruction using different cut-offs and to present lung function data from the Lolland-Falster Health Study, set in a rural-provincial area. Methods: Descriptive analysis of participant characteristics and self-reported respiratory disease and of spirometry results in the total population and in subgroups defined by these characteristics. Airway obstruction was assessed using previously published Danish reference values and defined according to either FEV
1/FVC below lower limit of normal (LLN) 5% (as in clinical diagnosis) or 2.5% (suggested for population studies), or as FEV
1/FVC < 70%. Results: Using either FEV
1/FVC < 70% or LLN 5% cut-off, 19.0% of LOFUS participants aged 35 years or older had spirometry, suggesting airway obstruction. By the LLN 2.5% criterion, the proportion was considerably lower, 12.2%. The prevalence of airway obstruction was higher among current smokers, in participants with short education or reporting low leisure-time physical activity and in those with known respiratory disease. Approximately 40% of participants reporting known respiratory disease had normal spirometry, and 8.7% without known respiratory disease had airway obstruction. Conclusion: Prevalence of airway obstruction in this rural population was comparable to previous estimates from urban Danish population studies. The choice of cut-off impacts the estimated prevalence, and using the FEV
1/FVC cut-off may overestimate prevalence. However, many participants with known respiratory disease had normal spirometry in this health study.
UR - https://www.scopus.com/pages/publications/85137370378
U2 - 10.1111/crj.13536
DO - 10.1111/crj.13536
M3 - Journal article
SN - 1752-6981
VL - 16
SP - 657
EP - 668
JO - The Clinical Respiratory Journal
JF - The Clinical Respiratory Journal
IS - 10
ER -